Similar articles

• Total resolution of ocular Kaposi sarcoma with different treatment approaches - a case series and review of literature.

  Yeak J, Iqbal T, Zahari M, Ismail F. Yeak J, et al. Int J STD AIDS. 2019 Jul;30(8):802-809. doi: 10.1177/0956462418825353. Epub 2019 May 2. Int J STD AIDS. 2019. PMID: 31046617 Review. No abstract available.
• Long-term prognosis of HIV-infected patients with Kaposi sarcoma treated with pegylated liposomal doxorubicin.

  Martín-Carbonero L, Palacios R, Valencia E, Saballs P, Sirera G, Santos I, Baldobí F, Alegre M, Goyenechea A, Pedreira J, González del Castillo J, Martínez-Lacasa J, Ocampo A, Alsina M, Santos J, Podzamczer D, González-Lahoz J; Caelyx/Kaposi's Sarcoma Spanish Group. Martín-Carbonero L, et al. Clin Infect Dis. 2008 Aug 1;47(3):410-7. doi: 10.1086/589865. Clin Infect Dis. 2008. PMID: 18582203 Clinical Trial.
• Triple secondary neoplasms: penis, lip and oral cavity in an AIDS patient treated with pegylated liposomal doxorubicin for cutaneous Kaposi's sarcoma.

  Volkow P, Lizano M, Carrillo-García A, Pérez-Montiel D, Garciadiego P. Volkow P, et al. AIDS. 2014 Sep 24;28(15):2327-9. doi: 10.1097/QAD.0000000000000420. AIDS. 2014. PMID: 25313589 No abstract available.
• Timing of highly active antiretroviral therapy and chemotherapy for Kaposi's sarcoma in patients with HIV infection.

  Loke WC, Spittle MF, Mitchell S, Kulasegaram R. Loke WC, et al. Int J STD AIDS. 2006 Aug;17(8):565-6. doi: 10.1258/095646206778145668. Int J STD AIDS. 2006. PMID: 16925908
• [HAART and changes of epidemiology, treatment and prognosis of HIV-positive patients with Kaposi's sarcoma and lymphoma].

  Gabarre J, Bossi P. Gabarre J, et al. Bull Cancer. 2003 May;90(5):419-25. Bull Cancer. 2003. PMID: 12850765 Review. French.